Braden Michael Leonard, 10% Owner at Aclaris Therapeutics, Inc. (ACRS), bought 541,113 shares at $1.29 ($688K) on 2024-08-02, disclosed to the SEC on 2024-08-05.
Open-market purchase of $688k ACRS by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.29 | 167,544 | $216K | 31.4% |
| 2 | $1.29 | 167,544 | $216K | 31.4% |
| 3 | $1.24 | 206,025 | $255K | 37.1% |
| Total | $1.27 avg | 541,113 | $688K | 100% |
| Filing → |
| ADVM | SELL | 2025-12-03 | $3.6M | — | Filing → |
| ASTC | SELL | 2025-10-07 | $3.2M | — | Filing → |
| ANTX | SELL | 2025-06-16 | $436K | — | Filing → |